Peri-operative Vitamin D Therapy for Hepatectomy
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Dec 6, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
Participants will receive short-term high dose of vitamin D during perioperative period.
The main questions the study aims to answer are:
1. If vitamin D therapy benefits perioperative care
2. If short-term high dose of vitamin D supplement is safe
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 20 years
- • Patients will undergo hepatectomy for hepatocellular carcinoma.
- Exclusion Criteria:
- • Patients with hypercalcemia, hyperparathyroidism, sarcoidosis, multiple myeloma
Trial Officials
Yin-Yi Han, PHD
Principal Investigator
National Taiwan University Hospital
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials